Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients

Journal of Surgical Oncology

Volumn 99, Issue 5, 2009, Pages 307-310

  Tanaka, Koji ^a,d   Mohri, Yasuhiko ^a   Nishioka, Junji ^b   Kobayashi, Minako ^c   Ohi, Masaki ^a   Miki, Chikao ^a   Tonouchi, Hitoshi ^c   Nobori, Tsutomu ^b   Kusunok, Masato ^a,c  

^a Department of Gastrointestinal and Pediatric Surgery ^*  (Japan)

^b MIE UNIVERSITY   (Japan)

^c University of Tokyo   (Japan)

^d MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Prognostic marker; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MESSENGER RNA; TROPOMYOSIN; NERVE GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; UNIVARIATE ANALYSIS; ADENOCARCINOMA; CANCER STAGING; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; MORTALITY; PATHOLOGY; PERITONEUM TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; RECEPTOR, TRKB; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 62849111354     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21232     Document Type: Article

References (22)

1. Douma S, Van Laar T, Zevenhoven J, et al.: Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004;430:1034-1039.
2. Liotta LA, Kohn E: Anoikis: Cancer and the homeless cell. Nature 2004;430:973-974.
3. Geiger TR, Peeper DS: The neurotrophic receptor TrkB in anoikis resistance and metastasis: A perspective. Cancer Res 2005 ;65: 7033-7036.
4. Schramm A, Schulte JH, Astrahantseff K, et al.: Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett 2005;228:143-153.
5. Nakamura K, Martin KC, Jackson JK, et al.: Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-lalpha in neuroblastoma cells. Cancer Res 2006;66:4249-4255.
6. Aoyama M, Asai K, Shishikura T, et al.: Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 2001;164:51-60.
7. Ho R, Eggert A, Hishiki T, et al.: Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 2002:62:6462-6466.
8. Tajima Y, Molina RP, Jr., Rorke LB, et al.: Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors. Acta Neuropathol (Berl) 1998;95: 325-332.
9. Eggert A, Grotzer MA, Ikegaki N, et al.: Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. J Clin Oncol 2001;19:689-696.
10. Weeraratna AT, Arnold JT, George DJ, et al.: Rational basis for Trk inhibition therapy for prostate cancer. Prostate 2000;45:140-148.
11. Montano X, Djamgoz MB: Epidermal growth factor, neuro-trophins and the metastatic cascade in prostate cancer. FEBS Lett 2004;571:1-8.
12. Ricci A, Greco S, Mariotta S, et al: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 2001;25:439-446.
13. Ketterer K, Rao S, Friess H, et al.: Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res 2003;9:5127-5136.
14. Sclabas GM, Fujioka S, Schmidt C, et al.: Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 2005; 11:440-449.
15. Yang ZF, Ho DW, Lam CT, et al.: Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res 2005;65:219-225.
16. Hartgrink HH, van de Velde CJ: Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005;90:153-165. Review.
17. Novotný AR, Schuhmacher C, Busch R, et al.: Predicting individual survival after gastric cancer resection: Validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg 2006;243:74-81.
18. Zhang Y, Fujiwara Y, Doki Y, et al.: Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma. Oncology 2008;75:17-26.
19. Japanese Research Society for Gastric Cancer: Japanese classi-fication of gastric carcinoma. First English Edition. Tokyo (Japan): Kanehara & Co., Ltd.; 1993.
20. Yie SM, Yang H, Ye SR, et al.: Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007;14:2721-2729.
21. Wang LH, Kim SH, Lee JH, et al.: Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res 2007;13:102-110.
22. Mrena J, Wiksten JP, Kokkola A, et al.: Prognostic significance of cyclin A in gastric cancer. Int J Cancer 2006:119:1897-1901.